HRP20171149T1 - Oralni farmaceutski pripravak koji sadrži tvar za prikrivanje ukusa n-acetilcisteina - Google Patents

Oralni farmaceutski pripravak koji sadrži tvar za prikrivanje ukusa n-acetilcisteina Download PDF

Info

Publication number
HRP20171149T1
HRP20171149T1 HRP20171149TT HRP20171149T HRP20171149T1 HR P20171149 T1 HRP20171149 T1 HR P20171149T1 HR P20171149T T HRP20171149T T HR P20171149TT HR P20171149 T HRP20171149 T HR P20171149T HR P20171149 T1 HRP20171149 T1 HR P20171149T1
Authority
HR
Croatia
Prior art keywords
particle
coating
polysorbate
acetylcysteine
core
Prior art date
Application number
HRP20171149TT
Other languages
English (en)
Inventor
Karin Becker
Detlev HAACK
Sharareh SALAR BEHZADI
Andreas Zimmer
Original Assignee
Hermes Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermes Arzneimittel Gmbh filed Critical Hermes Arzneimittel Gmbh
Publication of HRP20171149T1 publication Critical patent/HRP20171149T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5123Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (11)

1. Obložena čestica koja sadrži jezgru i prevlaku, pri čemu jezgra sadrži N-acetilcistein, i gdje prevlaka sadrži triglicerid odabran između gliceril tripalmitata i gliceril tristearata i površinski aktivnu tvar, pri čemu je površinski aktivna tvar polisorbat.
2. Čestica prema zahtjevu 1, naznačena time, da je polisorbat polisorbat 65.
3. Čestica prema bilo kojem prethodnom zahtjevu, naznačena time, da prevlaka sadrži 70 do 90 tež.% triglicerida i 10 do 30 tež.% polisorbata.
4. Čestica prema zahtjevu 3, naznačena time, da se prevlaka suštinski sastoji od triglicerida i polisorbata.
5. Čestica prema bilo kojem prethodnom zahtjevu, naznačena time, da težina ovojnice iznosi od 20 do 70 tež.% u odnosu na ukupnu težinu obložene čestice.
6. Čestica prema bilo kojem prethodnom zahtjevu, naznačena time da se jezgra suštinski sastoji od N-acetilcisteina.
7. Farmaceutski pripravak, naznačen time, da sadrži česticu iz bilo kojeg od zahtjeva 1 do 6.
8. Farmaceutski pripravak prema patentnom zahtjevu 7, naznačen time da je formuliran kao granule, kao što su disperzibilne granule, šumeće granule, granule izravno na usta ili kao tablete, kao što su disperzibilne tablete, šumeće tablete ili tablete za oralno dezintegriranje.
9. Postupak za pripravu čestice iz bilo kojeg od zahtjeva 1 do 6, naznačen time, da obuhvaća korake: a) snabdjevanje česticom jezgre koja sadrži N-acetilcistein, (b) snabdjevanje pripravkom za premazivanje koji sadrži rastaljeni triglicerid i površinski aktivno sredstvo, i (d) prevlačenje jezgre čestice sa smjesom za prevlačenje.
10. Postupak prema zahtjevu 9, naznačen time, da se temperatura produkta održava između oko 20 i 50 ° C tijekom izvođenja koraka (c).
11. Postupak prema zahtjevu 9 ili 10, naznačen time, da se korak (c) provodi u premazivaču s fluidnim slojem ili premazivaču sa zračnim protokom.
HRP20171149TT 2013-04-12 2017-07-27 Oralni farmaceutski pripravak koji sadrži tvar za prikrivanje ukusa n-acetilcisteina HRP20171149T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13163638 2013-04-12
EP14716609.4A EP2983650B1 (en) 2013-04-12 2014-04-11 Oral pharmaceutical composition comprising taste-masked n-acetylcysteine
PCT/EP2014/057442 WO2014167124A1 (en) 2013-04-12 2014-04-11 Oral pharmaceutical composition comprising taste-masked n-acetylcysteine

Publications (1)

Publication Number Publication Date
HRP20171149T1 true HRP20171149T1 (hr) 2017-10-06

Family

ID=48050614

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171149TT HRP20171149T1 (hr) 2013-04-12 2017-07-27 Oralni farmaceutski pripravak koji sadrži tvar za prikrivanje ukusa n-acetilcisteina

Country Status (11)

Country Link
US (1) US9636307B2 (hr)
EP (1) EP2983650B1 (hr)
DK (1) DK2983650T3 (hr)
ES (1) ES2638789T3 (hr)
HR (1) HRP20171149T1 (hr)
HU (1) HUE033723T2 (hr)
LT (1) LT2983650T (hr)
PL (1) PL2983650T3 (hr)
PT (1) PT2983650T (hr)
SI (1) SI2983650T1 (hr)
WO (1) WO2014167124A1 (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3157506T3 (da) * 2014-06-20 2020-11-23 Hermes Arzneimittel Gmbh Smagsmaskeret oral, farmaceutisk sammensætning
RU2667637C1 (ru) * 2017-06-26 2018-09-21 Гермес Арцнаймиттель ГмбХ Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом
BR112021002157A2 (pt) 2018-10-22 2021-05-04 Ioi Oleo Gmbh material de revestimento para uso em um método de revestimento hot-melt, combinação de material de revestimento e método de revestimento hot-melt
US11590090B2 (en) * 2019-09-14 2023-02-28 Anzen Pharmaceuticals, LLC Acetaminophen formulation with protection against toxic effects of overdose
US20220370368A1 (en) 2019-10-31 2022-11-24 Hermes Pharma Gmbh Oral pharmaceutical composition comprising a melt-agglomerated active ingredient core
CN113750052B (zh) * 2021-10-19 2022-11-18 桂林华信制药有限公司 一种乙酰半胱氨酸颗粒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE839528T1 (de) 1996-10-29 1998-10-22 Staroil Ltd Mundlösliche Zusammensetzungen die N-Acetylcystein und Cyclodextrin enthalten
US5891476A (en) 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20060034937A1 (en) * 1999-11-23 2006-02-16 Mahesh Patel Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
DE102006059510A1 (de) 2006-12-14 2008-06-19 Grünenthal GmbH Beschichtete Pellets
ITPD20070049A1 (it) 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
EP2198859A1 (en) 2008-12-17 2010-06-23 Losan Pharma GmbH Melt-coated pharmaceutical composition with fast release

Also Published As

Publication number Publication date
ES2638789T3 (es) 2017-10-24
PT2983650T (pt) 2017-09-01
LT2983650T (lt) 2017-09-11
EP2983650B1 (en) 2017-06-28
DK2983650T3 (en) 2017-09-18
US20160067189A1 (en) 2016-03-10
EP2983650A1 (en) 2016-02-17
HUE033723T2 (en) 2018-01-29
PL2983650T3 (pl) 2017-11-30
SI2983650T1 (sl) 2017-12-29
WO2014167124A1 (en) 2014-10-16
US9636307B2 (en) 2017-05-02

Similar Documents

Publication Publication Date Title
HRP20171149T1 (hr) Oralni farmaceutski pripravak koji sadrži tvar za prikrivanje ukusa n-acetilcisteina
CL2013001017A1 (es) Composicion detergente en particulas, empacada, que comprende mas del 40% en peso del surfactante detergente, y al menos 70% en numero de las particulas contienen un nucleo con surfactante, y alrededor un recubrimiento soluble en agua en una cantidad entre 10 a 45% en peso de base a la particula recubierta; y procedimiento para el lavado
HRP20191439T1 (hr) Formulacije 3-(6-(1-(2.2-difluorobenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzojeve kiseline
MX2016007134A (es) Composiciones farmaceuticas mejoradas de pimobendan.
HRP20200859T1 (hr) Meke kapsule kalcifediola
EA201391483A1 (ru) Фармацевтическая композиция
HRP20201863T1 (hr) Oralni farmaceutski sastav sa zamaskiranim okusom
HRP20160203T1 (hr) Pripravci koji sadrže 15-hepe i postupci njihove upotrebe
HRP20211606T1 (hr) Oralni farmaceutski pripravci dabigatran-eteksilata
BR112015012469A2 (pt) pó formado de partículas, mais do que 95% em número de ditas partículas exibindo uma circularidade superior ou igual a 0,85, processo para a fabricação de um pó, processo de pulverização térmica e câmara de tratamento para semicondutores
CO6531471A2 (es) Cápsulas resistentes a ácido
BR112015012547A2 (pt) composições de prostaciclina e métodos de sua utilização
SI2207526T1 (en) A process for the manufacture of a pharmaceutical product comprising citric acid, magnesium oxide, potassium bicarbonate and sodium picosulfate, a pharmaceutical composition comprising the granules obtained according to such a process and its intermediates
HRP20230021T1 (hr) Fungicidni pripravci
WO2015003478A3 (zh) 一种适用于婴幼儿及儿童的口腔崩解片及其制备方法
HRP20161340T1 (hr) Formulacije darunavira
RS54329B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RIFAXIMINE, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS
JP2013529072A5 (hr)
ATE466923T1 (de) Umhüllte natriumpercarbonatpartikel
HRP20171266T1 (hr) Čvrsti dozni oblik koji sadrži hidroksialkilcelulozu niskog viskoziteta
MX2015014952A (es) Composiciones de cera coloreada.
RS54632B1 (en) LIQUID PHARMACEUTICAL COMPOSITION CONTAINING NITIZINON
HRP20151347T1 (hr) Nova kombinacija
HRP20231360T1 (hr) Mješavina biljnih ekstrakata za uporabu u prevenciji i/ili liječenju kroničnih upalnih bolesti crijeva
NZ589261A (en) Process for manufacturing chewing gum by wetting a gum core and coating it with a substance